aTyr Pharma to Present at Jefferies 2017 Global Healthcare Conference
May 31 2017 - 9:00AM
aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged
in the discovery and development of Physiocrine-based therapeutics
to address severe, rare diseases, today announced the Company's
participation at the Jefferies 2017 Global Healthcare Conference to
be held in New York City from June 6 - 9, 2017.
The aTyr management team will present an overview of the Company
during a presentation at 2:00 p.m. ET on Friday, June 9, 2017. The
presentation will be webcast live through the "Investors" section
of the aTyr Pharma website at www.atyrpharma.com. An
audio replay will be available for at least 30 days following the
initial presentation webcast.
About aTyr Pharma
aTyr Pharma is engaged in the discovery and clinical development
of innovative medicines for patients suffering from severe, rare
diseases using its knowledge of Physiocrine biology, a newly
discovered set of physiological pathways. To date, the Company has
generated three innovative therapeutic candidate programs based on
its knowledge of Physiocrine biology in three different therapeutic
areas. aTyr has built an intellectual property estate, to protect
its pipeline, comprising over 190 issued patents or allowed patent
applications that are owned or exclusively licensed, including over
300 potential Physiocrine-based protein compositions. aTyr's key
programs are currently focused on severe, rare diseases
characterized by immune imbalance for which there are currently
limited or no treatment options. For more information, please visit
http://www.atyrpharma.com.
Contact:
Mark Johnson
Sr. Director, Investor Relations
mjohnson@atyrpharma.com
858-223-1163
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2023 to Apr 2024